Author

Keiko Ishimoto

VLP Therapeutics (United States)ORCID 0000-0002-9188-6702Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Davis Leitner· 1 shared Dhanya K. NambiariD· 1 shared Forrest Bowling· 1 shared Fred M. BaikiD· 1 shared Fumiya TaoiD· 1 shared Hongbin CaoiD· 1 shared Ivan Stephanek· 1 shared Jaya Sastri· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Davis Leitner

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 7, 2025

Alphavirus replicon particle expressing IL-12 reprograms tumor-associated macrophages and neutrophils and induces anti-tumor immunity

Momoko Ishikawa, Dhanya K. Nambiar, Jaya Sastri…·Wataru Akahata

This study uses an alphavirus replicon particle expressing IL-12 to reprogram immunosuppressive tumor-associated macrophages and neutrophils, enhancing anti-tumor immunity and reducing tumor growth in mouse models.

DOI 10.1101/2025.08.07.666585

mousebulk RNA-seq